Nurse Practitioner in Copiague, NY Accepting Medicare

3 Nurse Practitioner nurses found. Showing 1 - 3

Tanya Monique Sydnor Holmes, PMHNP Nurse Practitioner - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 445 Oak St, Copiague, NY 11726 Phone: 631-786-0147

Stacyann M Evans, Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 160 Beachview St, Copiague, NY 11726 Phone: 631-464-1497

Christopher Zeoli, NPP Nurse Practitioner - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 445 Oak St, Fegs Counseling Center, Copiague, NY 11726 Phone: 631-691-7080

News Archive

Calcium intake does not increase risk of coronary artery calcification

Researchers at the Institute for Aging Research (IFAR) at Hebrew SeniorLife, an affiliate of Harvard Medical School (HMS), have published a study that shows no evidence of a link between calcium intake and coronary artery calcification, reassuring adults who take calcium supplements for bone health that the supplements do not appear to result in the development of calcification of blood vessels.

Study: Having high-calorie dessert first may lead to eating lower-calorie meals

If you're going to choose dessert first, then the high-calorie option might lead to your eating a healthier meal, unless you have a lot on your mind, according to new research published by the American Psychological Association.

Autism Speaks releases biological and clinical data from 383 new AGRE families

Autism Speaks, the world's leading autism science and advocacy organization, is proud to announce the release of biological and clinical data from 383 new families participating in Autism Speaks Autism Genetic Resource Exchange (AGRE) to researchers. AGRE is a resource for scientists that is comprised of clinical and biological data from families who have two or more children on the autism spectrum.

Zymeworks, ImClone Systems partner to develop novel bi-specific antibody oncology therapeutics

Zymeworks Inc. today announced that it has entered into a licensing and collaboration agreement with ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to develop an undisclosed number of novel bi-specific antibody oncology therapeutics using Zymeworks' proprietary Azymetric platform. Bi-specific antibodies have the potential to provide improved outcomes for patients by simultaneously targeting two tumor associated antigens to induce a synergistic therapeutic response.

Read more Medical News

› Verified 8 days ago